Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer. - Sakatani T; Tanaka S; Murakami K; Jinno C; Aguilar F; Bresee C; Chan OTM; Luthringer DJ; Contreras-Sanz A; Black P; Rosser CJ; Furuya H (Experimental and molecular pathology, 2026)